In this video interview, David Morton, PhD, director of biostatistics at Certara, outlines how increasing FDA support is ...
When is it worth it for a team to roll the dice on a prospect, and when are they better off taking a more traditional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results